Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort-Reference-Cited by-同舟云学术

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Published:2019-03 Issue: Volume:109 Page:36-50
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Smeland Sigbjørn,Bielack Stefan S.,Whelan Jeremy,Bernstein Mark,Hogendoorn Pancras,Krailo Mark D.,Gorlick Richard,Janeway Katherine A.,Ingleby Fiona C.,Anninga Jakob,Antal Imre,Arndt Carola,Brown Ken L.B.,Butterfass-Bahloul Trude,Calaminus Gabriele,Capra Michael,Dhooge Catharina,Eriksson Mikael,Flanagan Adrienne M.,Friedel Godehard,Gebhardt Mark C.,Gelderblom Hans,Goldsby Robert,Grier Holcombe E.,Grimer Robert,Hawkins Douglas S.,Hecker-Nolting Stefanie,Sundby Hall Kirsten,Isakoff Michael S.,Jovic Gordana,Kühne Thomas,Kager Leo,von Kalle Thekla,Kabickova Edita,Lang Susanna,Lau Ching C.,Leavey Patrick J.,Lessnick Stephen L.,Mascarenhas Leo,Mayer-Steinacker Regine,Meyers Paul A.,Nagarajan Raj,Randall R.Lor,Reichardt Peter,Renard Marleen,Rechnitzer Catherine,Schwartz Cindy L.,Strauss Sandra,Teot Lisa,Timmermann Beate,Sydes Matthew R.^ORCID,Marina Neyssa

Funder

UK Medical Research Council

Federal Ministry of Education and Research

Deutsche Krebshilfe

Deutsche Forschungsgemeinschaft

European Science Foundation

Lilly

Bayer

Pfizer

Novartis

Isofol

Clinigen